SHL Telemedicine Ltd. announced that it has expanded its offering in Israel to include the ability to perform at-home Biomarker blood tests. This diagnostic tool is designed to rapidly identify cardiac markers for detection of a heart attack, transforming emergency cardiac care with speed and precision. Following concerns of a cardiac event, the addition of the Biomarker test provides a comprehensive snapshot, similar to an emergency room assessment, by combining this novel blood test with a detailed medical history (anamnesis) and a 12-lead ECG transmission.

This trio of diagnostic elements, now all available from home with SHL Telemedicine, will aid in identifying cardiac events quickly during the critical symptomatic phase, thus helping save lives. When a potential cardiac event is suspected, the Biomarker test is administered as the final step in the diagnosis process, following anamnesis and ECG broadcasting. SHL's telemedicine team guides the patient in real-time on how to perform the blood test and continues support until emergency medical services arrive.